Risk factor
Very poor trading liquidity
Profitability factor
Very favourable analyst view
About
Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company operates through two segments, Analytical Products and Life Science Solutions. It offers analytical products, including syringes, GC consumables, septas, caps, liners,...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is of fair value on EV/EBITDA, undervalu
Target Price
The average target price of TRJ.AX is 1.2 and suggests 87% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell